$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC.

2022 Q4 Form 10-Q Financial Statement

#000155335022000896 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $2.114M $2.117M $2.043M
YoY Change 2.47% 6.25%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $860.0K $1.015M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.180K $16.10K
YoY Change
% of Gross Profit
Operating Expenses $1.089M $1.266M
YoY Change
Operating Profit
YoY Change
Interest Expense -$774.9K $641.8K $484.8K
YoY Change 55.6% 6.4%
% of Operating Profit
Other Income/Expense, Net $33.55K $46.22K
YoY Change -6.85% -6.69%
Pretax Income $249.6K $208.9K $253.1K
YoY Change -44.63% 25.96%
Income Tax $8.600K $54.19K $67.78K
% Of Pretax Income 3.45% 25.94% 26.78%
Net Earnings $211.9K $154.7K $185.4K
YoY Change -48.04% 18.84%
Net Earnings / Revenue 10.03% 7.31% 9.07%
Basic Earnings Per Share $0.04 $0.06
Diluted Earnings Per Share $0.06 $0.04 $0.05
COMMON SHARES
Basic Shares Outstanding 2.905M shares 2.905M shares 2.905M shares
Diluted Shares Outstanding 3.454M shares 3.130M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $421.2K $96.85K
YoY Change
Cash & Equivalents $421.2K $96.85K $184.2K
Short-Term Investments
Other Short-Term Assets $348.8K $199.6K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.24M $52.97M $51.14M
YoY Change 6.38%
LONG-TERM ASSETS
Property, Plant & Equipment $103.6K $85.82K $91.61K
YoY Change 23.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $892.0K $940.1K
YoY Change
Total Long-Term Assets $1.244M $1.305M $1.246M
YoY Change -3.18%
TOTAL ASSETS
Total Short-Term Assets $50.24M $52.97M $51.14M
Total Long-Term Assets $1.244M $1.305M $1.246M
Total Assets $51.49M $54.28M $52.39M
YoY Change 6.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.440M $1.459M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $34.54M $37.50M
YoY Change
Long-Term Debt Due $1.554M $1.038M
YoY Change
Total Short-Term Liabilities $37.54M $40.00M $38.69M
YoY Change -0.2%
LONG-TERM LIABILITIES
Long-Term Debt $7.927M $8.441M
YoY Change
Other Long-Term Liabilities $73.85K $103.5K
YoY Change
Total Long-Term Liabilities $8.001M $8.544M $8.102M
YoY Change 25.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.54M $40.00M $38.69M
Total Long-Term Liabilities $8.001M $8.544M $8.102M
Total Liabilities $45.54M $48.55M $46.79M
YoY Change 3.53%
SHAREHOLDERS EQUITY
Retained Earnings $2.566M $2.354M $2.224M
YoY Change 38.78%
Common Stock $2.905K $2.905K $2.905K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.952M $5.733M $5.597M
YoY Change
Total Liabilities & Shareholders Equity $51.49M $54.28M $52.39M
YoY Change 6.12%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income $211.9K $154.7K $185.4K
YoY Change -48.04% 18.84%
Depreciation, Depletion And Amortization $6.180K $16.10K
YoY Change
Cash From Operating Activities -$47.32K $1.672M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $23.95K $24.80K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $3.097M -$6.672M
YoY Change
Cash From Investing Activities $3.074M -$6.696M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.702M 5.100M
YoY Change
NET CHANGE
Cash From Operating Activities -47.32K 1.672M
Cash From Investing Activities 3.074M -6.696M
Cash From Financing Activities -2.702M 5.100M
Net Change In Cash 324.4K 75.86K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$47.32K $1.672M
Capital Expenditures $23.95K $24.80K
Free Cash Flow -$71.27K $1.647M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
538139 usd
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56243
dei Entity Registrant Name
EntityRegistrantName
STANDARD PREMIUM FINANCE HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2624094
dei Entity Address Address Line1
EntityAddressAddressLine1
13590 SW 134 th Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 214
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q3 us-gaap Cash
Cash
96848 usd
CY2021Q4 us-gaap Cash
Cash
20987 usd
CY2022Q3 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
52677309 usd
CY2021Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
46674273 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199601 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001807893
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33186
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
232-2752
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2905016 shares
CY2022Q3 us-gaap Assets Current
AssetsCurrent
52973758 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47233399 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85824 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83794 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224324 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228954 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
55234 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
65176 usd
CY2022Q3 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
596087 usd
CY2021Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
559877 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
344000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
347000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
940087 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
906877 usd
CY2022Q3 us-gaap Assets
Assets
54279227 usd
CY2021Q4 us-gaap Assets
Assets
48518200 usd
CY2022Q3 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
153264 usd
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
35363636 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
30476375 usd
CY2022Q3 srt Drafts Payable
DraftsPayable
2141140 usd
CY2021Q4 srt Drafts Payable
DraftsPayable
1935278 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
896756 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2285023 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
37000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
862000 usd
CY2022Q3 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
91620 usd
CY2021Q4 spfx Payroll Protection Program Loan Current Portion
PayrollProtectionProgramLoanCurrentPortion
271000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
120791 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104880 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12332 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11857 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1338192 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1512528 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
40001467 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37612205 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
6372054 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4964787 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1878000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1229302 usd
CY2022Q3 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
146975 usd
CY2021Q4 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
0 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103533 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124074 usd
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43744 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
53053 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8544306 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6371216 usd
CY2022Q3 us-gaap Liabilities
Liabilities
48545773 usd
CY2021Q4 us-gaap Liabilities
Liabilities
43983421 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 spfx Designated Shares
DesignatedShares
600000 shares
CY2021Q4 spfx Designated Shares
DesignatedShares
600000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
166000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
166000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
99000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
99000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
166 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
99 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2905 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3376601 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2682995 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2353782 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1848780 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5733454 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4534779 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54279227 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48518200 usd
CY2022Q3 us-gaap Revenues
Revenues
2117116 usd
CY2021Q3 us-gaap Revenues
Revenues
2066048 usd
us-gaap Revenues
Revenues
6042694 usd
us-gaap Revenues
Revenues
5700779 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
641795 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
412467 usd
us-gaap Interest Expense
InterestExpense
1553101 usd
us-gaap Interest Expense
InterestExpense
1262938 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
423521 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
368733 usd
us-gaap Salaries And Wages
SalariesAndWages
1150828 usd
us-gaap Salaries And Wages
SalariesAndWages
1074298 usd
CY2022Q3 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
264365 usd
CY2021Q3 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
238104 usd
us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
762925 usd
us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
777130 usd
CY2022Q3 spfx Bad Debts
BadDebts
197573 usd
CY2021Q3 spfx Bad Debts
BadDebts
306382 usd
spfx Bad Debts
BadDebts
636822 usd
spfx Bad Debts
BadDebts
670427 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
95852 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
77681 usd
us-gaap Professional Fees
ProfessionalFees
289985 usd
us-gaap Professional Fees
ProfessionalFees
262563 usd
CY2022Q3 us-gaap Postage Expense
PostageExpense
27161 usd
CY2021Q3 us-gaap Postage Expense
PostageExpense
29356 usd
us-gaap Postage Expense
PostageExpense
81213 usd
us-gaap Postage Expense
PostageExpense
81516 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
33552 usd
CY2021Q3 us-gaap Other Expenses
OtherExpenses
36019 usd
us-gaap Other Expenses
OtherExpenses
123619 usd
us-gaap Other Expenses
OtherExpenses
131729 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
224384 usd
CY2021Q3 us-gaap Other General Expense
OtherGeneralExpense
220028 usd
us-gaap Other General Expense
OtherGeneralExpense
681466 usd
us-gaap Other General Expense
OtherGeneralExpense
604740 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1908203 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1688770 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5279959 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4865341 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
208913 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
377278 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
762735 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
835438 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54188 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79515 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197592 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
201448 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
154725 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
297763 usd
us-gaap Net Income Loss
NetIncomeLoss
565143 usd
us-gaap Net Income Loss
NetIncomeLoss
633990 usd
CY2022Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
25258 usd
CY2021Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
17325 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
60141 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
51975 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
129467 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
280438 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
505002 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
582015 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3454321 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2905016 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3454321 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4534779 usd
CY2022Q1 spfx Series A Convertible Preferred Stock Issued In Exchange For Note Payable
SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable
20000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5778 usd
CY2022Q1 spfx Distributions Preferred Shares
DistributionsPreferredShares
-17325 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225065 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4768297 usd
CY2022Q2 spfx Series A Convertible Preferred Stock Issued For Cash
SeriesAConvertiblePreferredStockIssuedForCash
400000 usd
CY2022Q2 spfx Series A Convertible Preferred Stock Issued In Exchange For Note Payable
SeriesAConvertiblePreferredStockIssuedInExchangeForNotePayable
250000 usd
CY2022Q2 spfx Warrants Issued For Services
WarrantsIssuedForServices
10800 usd
CY2022Q2 spfx Distributions Preferred Shares
DistributionsPreferredShares
-17558 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
185353 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
5596892 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7050 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
45 usd
CY2022Q3 spfx Distributions Preferred Shares
DistributionsPreferredShares
-25258 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
154725 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5733454 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3683812 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8667 usd
CY2021Q1 spfx Distributions Preferred Shares
DistributionsPreferredShares
-17325 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
180254 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3855408 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8667 usd
CY2021Q2 spfx Warrants Issued For Services
WarrantsIssuedForServices
9275 usd
CY2021Q2 spfx Distributions Preferred Shares
DistributionsPreferredShares
-17325 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
155973 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4011998 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8668 usd
CY2021Q3 spfx Distributions Preferred Shares
DistributionsPreferredShares
-17325 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
297763 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4301104 usd
us-gaap Net Income Loss
NetIncomeLoss
565143 usd
us-gaap Net Income Loss
NetIncomeLoss
633990 usd
us-gaap Depreciation
Depreciation
16103 usd
us-gaap Depreciation
Depreciation
25239 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2167 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
75668 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
76837 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9942 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
spfx Bad Debt Expense
BadDebtExpense
636822 usd
spfx Bad Debt Expense
BadDebtExpense
670427 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-45158 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-100950 usd
spfx Options Issued For Services
OptionsIssuedForServices
12828 usd
spfx Options Issued For Services
OptionsIssuedForServices
26002 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
10800 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
9275 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-338538 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
109843 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-3000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
125000 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
205862 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
403180 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-174336 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102278 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-75668 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-76837 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1672027 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1736498 usd
spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
6639858 usd
spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
10667657 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
36210 usd
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
35627 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4500 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24800 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33881 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6696368 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10737165 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-153264 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
143000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
181302 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
8834 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
-0 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4842103 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
7377338 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
400000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
32405 usd
spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
-0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
45 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
spfx Dividend Distributions Paid
DividendDistributionsPaid
60141 usd
spfx Dividend Distributions Paid
DividendDistributionsPaid
51975 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
505000 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
1216426 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-236000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-55000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5100202 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8604789 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
75861 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-395878 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20987 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477289 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96848 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81411 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
296059 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
359068 usd
us-gaap Interest Paid Net
InterestPaidNet
1475440 usd
us-gaap Interest Paid Net
InterestPaidNet
1275284 usd
spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
270000 usd
spfx Debt Exchanged For Series Convertible Preferred Stock
DebtExchangedForSeriesConvertiblePreferredStock
0 usd
spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
71038 usd
spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
235335 usd
us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.156 pure
us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.155 pure
CY2022Q3 spfx Plus Cash Overdraft
PlusCashOverdraft
0 usd
CY2021Q4 spfx Plus Cash Overdraft
PlusCashOverdraft
153264 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2018Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
31494613 usd
CY2022Q3 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
3687436 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
4426576 usd
CY2022Q3 us-gaap Unearned Premiums
UnearnedPremiums
75986257 usd
CY2021Q4 us-gaap Unearned Premiums
UnearnedPremiums
67929695 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zaL88snETxAg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zHhObVSrobZ9">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for doubtful accounts, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z9ef966AXdVq" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zEL9oAEiyIIt">Concentration of Credit and Financial Instrument Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and loans receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at these financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_c20220930_pp0p0_zjpHX7Sy6Yd4" title="FDIC insured amount">250,000</span>. Uninsured balances are $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_c20220930_pp0p0_zyM85FWw1rYA" title="Uninsured balances">134,790</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0_zRkfiEeg74Al" title="Uninsured balances">0</span> at September 30, 2022 and December 31, 2021, respectively. The Company mitigates this risk by maintaining its cash balances at high-quality financial institutions. The following table provides a reconciliation between uninsured balances and cash per the balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_z32pRsujSa4F" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc"> <span id="xdx_8B4_zF71PtXgWfka" style="display: none">Schedule of reconciliation between uninsured balances and cash per the balance sheet</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20220930_zUzfvEGnMvAP" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20211231_z8ThqVTIJrPz" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">September 30, <br/> 2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: center">(unaudited)</td><td style="font-size: 8pt"> </td><td style="font-size: 11pt"> </td> <td colspan="2" style="font-size: 11pt; text-align: center"> </td><td style="font-size: 11pt"> </td></tr> <tr id="xdx_409_eus-gaap--CashUninsuredAmount_iI_pp0p0_d0_zjT2GLkwlIAM" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 74%; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Uninsured Balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">134,790</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--PlusInsuredBalances_iI_pp0p0_d0_zV7htOOH1WFC" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit_iI_pp0p0_ztxuEeQCPh1m" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Plus: Balances at institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">102,379</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,179</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--PlusCashOverdraft_iI_pp0p0_d0_zjHT2jWu84Zt" style="vertical-align: bottom; background-color: transparent"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Plus: Cash overdraft</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,264</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--OutstandingChecks_iI_pp0p0_zYOFHh6sWpT4" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(390,321</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(325,456</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 11pt; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Cash_iI_pp0p0_z6XLPEIvvAuo" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Cash per Consolidated Balance Sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">96,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">20,987</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zYYV5rxb92f4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__srt--StatementGeographicalAxis__stpr--FL_z1nVd7DTtGN7" title="Concentration Risk, Percentage">57</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__srt--StatementGeographicalAxis__stpr--FL_zvp1UlOdqJMx" title="Concentration Risk, Percentage">51</span>% of the Company’s business activity is with customers located in Florida for 2022 and 2021, respectively. Approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__srt--StatementGeographicalAxis__stpr--GA_zQAAK3oTQONp" title="Concentration Risk, Percentage">13</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__srt--StatementGeographicalAxis__stpr--GA_ztr6GQq2gCf0" title="Concentration Risk, Percentage">22</span>% of the Company’s business activity is with customers located in Georgia for 2022 and 2021, respectively. Approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__srt--StatementGeographicalAxis__stpr--NC_zzbx55mUkqwd" title="Concentration Risk, Percentage">13</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__srt--StatementGeographicalAxis__stpr--NC_zMoJWINziZG_zav8F2OAkxY6" title="Concentration Risk, Percentage">14</span>% of the Company's business activity is with customers located in North Carolina for 2022 and 2021, respectively. There were no other significant regional, industrial or group concentrations during the nine months ended September 30, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
134790 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
134790 usd
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2022Q3 spfx Plus Insured Balances
PlusInsuredBalances
250000 usd
CY2021Q4 spfx Plus Insured Balances
PlusInsuredBalances
0 usd
CY2022Q3 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
102379 usd
CY2021Q4 spfx Plus Balances At Other Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtOtherInstitutionsThatDoNotExceedFdicLimit
193179 usd
CY2022Q3 spfx Outstanding Checks
OutstandingChecks
-390321 usd
CY2021Q4 spfx Outstanding Checks
OutstandingChecks
-325456 usd
CY2022Q3 us-gaap Cash
Cash
96848 usd
CY2021Q4 us-gaap Cash
Cash
20987 usd
CY2022Q3 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
596087 usd
CY2021Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
559877 usd
CY2019Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
36376185 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
187400 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
975000 shares
CY2018Q4 spfx Unearned Interest
UnearnedInterest
-1042593 usd
CY2022Q3 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
53869790 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
47868030 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zJcsCeAv8z73" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zvy3y2G3S1kS">Reclassification</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2021, the Company reconsidered its definition of related party when classifying its notes payable. The Company previously had recorded notes payable due to any stockholder as a related party note. Under the new classification, only notes payable to officers, directors, greater than 5% shareholders, and insiders are considered related party notes. See Footnote 10 and Footnote 11 for more information on the notes payable. The effect of this reclassification on the consolidated statement of cash flows for the nine months ended September 30, 2021 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_esrt--ScheduleOfCondensedCashFlowStatementTableTextBlock_z7rlrBQWk0Ng" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 10pt; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc"><span id="xdx_8B4_zE8KcEe15Ocq" style="display: none">Condensed Cash Flow Statement</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49D_20220101__20220930__us-gaap--ReclassificationTypeAxis__custom--BeforeReclassificationMember_zDu25ZHd5BZ5" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_492_20220101__20220930__us-gaap--ReclassificationTypeAxis__us-gaap--ReclassificationOtherMember_zrhJRS7D0rDf" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_491_20220101__20220930__us-gaap--ReclassificationTypeAxis__custom--AfterReclassificationMember_zKxYrJuz022j" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center">September 30, 2021</td><td style="font-size: 8pt; font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center">September 30, 2021</td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center">(before</td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center">Reclassification</td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold; text-align: center">(after</td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold">Consolidated Statement of Cash Flows Item</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">reclassification)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">amount</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">reclassification)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--ProceedsFromSecuredNotesPayable_i_pp0p0_zIj9pYc0ttRw" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="width: 61%; font-size: 10pt; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Proceeds from notes payable - other</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">866,426</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">350,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">1,216,426</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RepaymentOfNotesPayableOther_d0_zoXRWA6avs5S" style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 10pt; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Repayment of notes payable - other</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(55,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(55,000</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--ProceedsFromNotesPayableStockholdersAndRelatedParties_z2mIFR25sVWL" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font-size: 10pt; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Proceeds from notes payable - stockholders and related parties</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">493,000</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(350,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">143,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProceedsFromRepaymentsOfNotesPayable_d0_znaJBjaPSkLS" style="vertical-align: bottom; background-color: transparent"> <td style="font-size: 10pt; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Repayments of notes payable - stockholders and related parties</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(25,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">—</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(25,000</td><td style="font-size: 10pt; text-align: left">)</td></tr> </table> <p id="xdx_8A9_zLCoXYSrtFWY" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
51135890 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
44079251 usd
CY2019Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
3433680 usd
CY2018Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
3535127 usd
CY2022Q3 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
54823326 usd
CY2021Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
48505827 usd
CY2019Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
39809865 usd
CY2018Q4 spfx Insurance Premium Finance Contracts Gross
InsurancePremiumFinanceContractsGross
35029740 usd
CY2022Q3 spfx Amounts Due From Agents
AmountsDueFromAgents
731986 usd
CY2021Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
793869 usd
CY2019Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
951595 usd
CY2018Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
915770 usd
CY2022Q3 spfx Unearned Interest
UnearnedInterest
-1685522 usd
CY2021Q4 spfx Unearned Interest
UnearnedInterest
-1431666 usd
CY2019Q4 spfx Unearned Interest
UnearnedInterest
-1176554 usd
CY2019Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
39584906 usd
CY2018Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
34902917 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1192481 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1193757 usd
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
785532 usd
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
992153 usd
CY2022Q3 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
52677309 usd
CY2021Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
46674273 usd
CY2019Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
38799374 usd
CY2018Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
33910764 usd
CY2022Q3 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1007106 usd
CY2021Q4 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1000000 usd
CY2022Q3 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
185375 usd
CY2021Q4 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
193757 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1192481 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
76837 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
28051 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
24645 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
824342 usd
spfx Current Year Provision
CurrentYearProvision
1075000 usd
CY2021 spfx Current Year Provision
CurrentYearProvision
1353057 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1110528 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1212150 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
34252 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
228508 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1192481 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1193757 usd
CY2022Q3 spfx Total Provision
TotalProvision
360000 usd
CY2021Q3 spfx Total Provision
TotalProvision
400000 usd
CY2022Q3 spfx Contra Rrevenues
ContraRrevenues
-162427 usd
CY2021Q3 spfx Contra Rrevenues
ContraRrevenues
-93618 usd
CY2022Q3 spfx Bad Debt Expense
BadDebtExpense
197573 usd
CY2021Q3 spfx Bad Debt Expense
BadDebtExpense
306382 usd
spfx Total Provision
TotalProvision
1075000 usd
spfx Total Provision
TotalProvision
1031016 usd
spfx Contra Rrevenues
ContraRrevenues
438178 usd
spfx Contra Rrevenues
ContraRrevenues
333297 usd
spfx Less Current Year Provisions For Amounts Due From Agents
LessCurrentYearProvisionsForAmountsDueFromAgents
0 usd
spfx Less Current Year Provisions For Amounts Due From Agents
LessCurrentYearProvisionsForAmountsDueFromAgents
-27292 usd
spfx Bad Debt Expense
BadDebtExpense
636822 usd
spfx Bad Debt Expense
BadDebtExpense
670427 usd
CY2022Q3 srt Drafts Payable
DraftsPayable
2141140 usd
CY2021Q4 srt Drafts Payable
DraftsPayable
1935278 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
324452 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
308132 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
238628 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
224338 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85824 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83794 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16103 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25239 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5781 usd
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8683 usd
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0525 pure
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0525 pure
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224324 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228954 usd
CY2022Q3 spfx Server Lease
ServerLease
55234 usd
CY2021Q4 spfx Server Lease
ServerLease
65176 usd
CY2022Q3 spfx Total Lease Assets
TotalLeaseAssets
279558 usd
CY2021Q4 spfx Total Lease Assets
TotalLeaseAssets
294130 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
120791 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104880 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103533 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124074 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
224324 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
228954 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
12332 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
11857 usd
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43744 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
53053 usd
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
56076 usd
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
64910 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M2D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M26D
us-gaap Operating Lease Cost
OperatingLeaseCost
85610 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
7801 usd
CY2022Q3 spfx Ppp Loan
PppLoan
238595 usd
CY2021Q4 spfx Ppp Loan
PppLoan
271000 usd
CY2022Q3 spfx Current Maturities
CurrentMaturities
91620 usd
CY2021Q4 spfx Current Maturities
CurrentMaturities
-271000 usd
CY2022Q3 spfx Longterm Maturities
LongtermMaturities
146975 usd
CY2021Q4 spfx Longterm Maturities
LongtermMaturities
0 usd
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
39000 usd
CY2022Q3 us-gaap Other Notes Payable
OtherNotesPayable
7268810 usd
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
7249810 usd
CY2022Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
896756 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
2285023 usd
CY2022Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
6372054 usd
CY2021Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
4964787 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
377000 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
357000 usd
CY2022Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
126000 usd
CY2021Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
137000 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
505000 usd
us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
1216426 usd
spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
236000 usd
spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
55000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
250000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
25000 shares
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P8Y2M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
20000 shares
spfx Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
4.73
spfx Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm1
P7Y6M
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1915000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
2091302 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
37000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
862000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1878000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1229302 usd
us-gaap Interest Expense Other
InterestExpenseOther
119000 usd
us-gaap Interest Expense Other
InterestExpenseOther
120000 usd
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
42000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
143000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
181032 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000 usd
CY2022Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 spfx Designated Shares
DesignatedShares
600000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
166000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
166000 shares
CY2022Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
us-gaap Dividends
Dividends
60141 usd
us-gaap Dividends
Dividends
51975 usd
CY2022Q3 us-gaap Dividends
Dividends
25258 usd
CY2021Q3 us-gaap Dividends
Dividends
17325 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
17325000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
187400 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1630380 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
187400 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y5M1D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1630380 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12828 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
26002 usd
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7050 usd
CY2021Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
8668 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
975000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.28
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y5M15D
spfx Warrants Issued
WarrantsIssued
60000 shares
spfx Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
4.00
spfx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedWeightedAverageRemainingContractualTerms
P4Y11M1D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
spfx Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y9M29D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
3492500 usd
CY2022Q3 spfx Warrants Exercisable
WarrantsExercisable
1035000 shares
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y9M29D
CY2022Q3 spfx Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1
3492500 usd
CY2022Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
10800 usd
CY2021Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
9275 usd
CY2020Q2 spfx Warrant Issued For Services
WarrantIssuedForServices
27200 usd
CY2022Q3 spfx Stock Warrant Expense
StockWarrantExpense
0 usd
CY2021Q3 spfx Stock Warrant Expense
StockWarrantExpense
0 usd
spfx Stock Warrant Expense
StockWarrantExpense
10800 usd
spfx Stock Warrant Expense
StockWarrantExpense
9275 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
1915000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
2091302 usd
CY2022Q1 spfx Transaction Cost
TransactionCost
69338 usd
CY2022Q2 spfx Transaction Cost
TransactionCost
56400 usd

Files In Submission

Name View Source Status
0001553350-22-000896-index-headers.html Edgar Link pending
0001553350-22-000896-index.html Edgar Link pending
0001553350-22-000896.txt Edgar Link pending
0001553350-22-000896-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spfx-20220930.xsd Edgar Link pending
spfx_10q.htm Edgar Link pending
spfx_ex31z1.htm Edgar Link pending
spfx_ex31z2.htm Edgar Link pending
spfx_ex32z1.htm Edgar Link pending
spfx-20220930_cal.xml Edgar Link unprocessable
spfx-20220930_def.xml Edgar Link unprocessable
spfx-20220930_lab.xml Edgar Link unprocessable
spfx-20220930_pre.xml Edgar Link unprocessable
spfx_10q_htm.xml Edgar Link completed